Gu Huan, Jiang Huadong
Lianyungang Affiliated Hospital of Nanjing University of Chinese Medicine, LianYungang, 222000, Jiangsu, China.
Clin Exp Med. 2025 Sep 3;25(1):313. doi: 10.1007/s10238-025-01864-z.
To evaluate the implementation effects of problem-solving Quality Control Circle (QCC) activities on medication adherence among outpatient Helicobacter pylori patients. Pharmacists collected data scales, guidance sheets, registration forms, and scoring sheets from outpatient H. pylori patients from January to March 2024. Through brainstorming, factors affecting medication adherence were identified and a series of specific measures were formulated. Implementation was carried out from April to July 2024, and the therapeutic effects of patients before and after implementing the QCC process were evaluated. The total score of patient medication adherence improved from 7.9 to 9.2, with statistically significant results (P < 0.001). The medication compliance rate increased from 57.46% to 87.62%; the adverse reaction incidence decreased from 39 to 11%; the C14 breath test positive rate decreased from 67.2% to 30.65%. All the above results showed statistically significant differences (P < 0.001). Implementing QCC can standardize and improve medication adherence measures for H. pylori patients, which has practical significance for patient treatment outcomes, while also enhancing pharmacists' professional knowledge and skills.
评估解决问题式品管圈（QCC）活动对门诊幽门螺杆菌患者用药依从性的实施效果。药剂师收集了2024年1月至3月门诊幽门螺杆菌患者的数据量表、指导手册、登记表和评分表。通过头脑风暴，确定了影响用药依从性的因素，并制定了一系列具体措施。于2024年4月至7月实施，评估了实施QCC流程前后患者的治疗效果。患者用药依从性总分从7.9提高到9.2，结果具有统计学意义（P < 0.001）。用药依从率从57.46%提高到87.62%；不良反应发生率从39%降至11%；C14呼气试验阳性率从67.2%降至30.65%。以上所有结果均显示出统计学差异（P < 0.001）。实施QCC可规范并改善幽门螺杆菌患者的用药依从性措施，这对患者治疗结果具有实际意义，同时也提高了药剂师的专业知识和技能。
